Apoptotic cell death in disease—Current understanding of the NCCD 2023
I Vitale, F Pietrocola, E Guilbaud… - Cell Death & …, 2023 - nature.com
Apoptosis is a form of regulated cell death (RCD) that involves proteases of the caspase
family. Pharmacological and genetic strategies that experimentally inhibit or delay apoptosis …
family. Pharmacological and genetic strategies that experimentally inhibit or delay apoptosis …
Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins
R Singh, A Letai, K Sarosiek - Nature reviews Molecular cell biology, 2019 - nature.com
The loss of vital cells within healthy tissues contributes to the development, progression and
treatment outcomes of many human disorders, including neurological and infectious …
treatment outcomes of many human disorders, including neurological and infectious …
Immunogenic cell death and DAMPs in cancer therapy
Although it was thought that apoptotic cells, when rapidly phagocytosed, underwent a silent
death that did not trigger an immune response, in recent years a new concept of …
death that did not trigger an immune response, in recent years a new concept of …
[HTML][HTML] Autophagy and apoptosis dysfunction in neurodegenerative disorders
Autophagy and apoptosis are basic physiologic processes contributing to the maintenance
of cellular homeostasis. Autophagy encompasses pathways that target long-lived cytosolic …
of cellular homeostasis. Autophagy encompasses pathways that target long-lived cytosolic …
Multiple functions of BCL-2 family proteins
JM Hardwick, L Soane - Cold Spring Harbor …, 2013 - cshperspectives.cshlp.org
BCL-2 family proteins are the regulators of apoptosis, but also have other functions. This
family of interacting partners includes inhibitors and inducers of cell death. Together they …
family of interacting partners includes inhibitors and inducers of cell death. Together they …
Quiescent Sox2+ cells drive hierarchical growth and relapse in sonic hedgehog subgroup medulloblastoma
Functional heterogeneity within tumors presents a significant therapeutic challenge. Here
we show that quiescent, therapy-resistant Sox2+ cells propagate sonic hedgehog subgroup …
we show that quiescent, therapy-resistant Sox2+ cells propagate sonic hedgehog subgroup …
scRNA-seq in medulloblastoma shows cellular heterogeneity and lineage expansion support resistance to SHH inhibitor therapy
JK Ocasio, B Babcock, D Malawsky, SJ Weir… - Nature …, 2019 - nature.com
Targeting oncogenic pathways holds promise for brain tumor treatment, but inhibition of
Sonic Hedgehog (SHH) signaling has failed in SHH-driven medulloblastoma. Cellular …
Sonic Hedgehog (SHH) signaling has failed in SHH-driven medulloblastoma. Cellular …
[HTML][HTML] The role of Bcl-2 proteins in modulating neuronal Ca2+ signaling in health and in Alzheimer's disease
M Callens, N Kraskovskaya, K Derevtsova… - … et Biophysica Acta (BBA …, 2021 - Elsevier
The family of B-cell lymphoma-2 (Bcl-2) proteins exerts key functions in cellular health. Bcl-2
primarily acts in mitochondria where it controls the initiation of apoptosis. However, during …
primarily acts in mitochondria where it controls the initiation of apoptosis. However, during …
[HTML][HTML] Poly (2-oxazoline) nanoparticle delivery enhances the therapeutic potential of vismodegib for medulloblastoma by improving CNS pharmacokinetics and …
We report a nanoparticle formulation of the SHH-pathway inhibitor vismodegib that improves
efficacy for medulloblastoma, while reducing toxicity. Limited blood–brain barrier (BBB) …
efficacy for medulloblastoma, while reducing toxicity. Limited blood–brain barrier (BBB) …
Hexokinase-2-mediated aerobic glycolysis is integral to cerebellar neurogenesis and pathogenesis of medulloblastoma
Background While aerobic glycolysis is linked to unconstrained proliferation in cancer, less
is known about its physiological role. Why this metabolic program that promotes tumor …
is known about its physiological role. Why this metabolic program that promotes tumor …